中文
English
About Us
Company
Team
Honor
Vision & Mission
Contact Us
Pipeline
Innovation
Biosimilar
R & D
Antibody Screening
Pharmacodynamics
Protein/Ab Engineering
Process Dev
Multi-functional Fc platform
While the specificity of mAbs are fully appreciated, at the early days, scien...
In vitro/In vivo Pharmaco...
In vitro/In vivo Pharmacology Evaluation Platform in Alphamab including cell b...
Manufacturing
Pilot Production
Quality System
Partnering
Opportunities
Corporation
Academic
News
Press Release
Worth to be Noted
Career
Career opportunity
Apply On-line
Pipeline
Innovation
Biosimilar
---- Useful Link ----
Alphamab Jilin
DingFu Biotarget
Shihuida Pharma
CFDA
CDE
NIFDC
Innovation
Home
>
Pipeline
>
Innovation
Field
Target
Technology
H2L
L-Opt.
PreClin
Phase I
KN057
Hematology
Coagulation
Novel mAb
KN059
Infection, Orphan Drug
N.A.
Novel dAb, Multi-spec
KN043
Infection
MRSA
Novel dAb, Multi-spec
Home
|
About Us
|
Pipeline
|
R & D
|
Manufacturing
|
Partnering
|
News
|
Career
